In the health care facilities complex, insiders have snapped up a decent amount of shares in LHC Group (LHCG), which provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. Insiders have spotted some deep value here since this stock is off by over 40% in the last six months.
LHC Group has a market cap of $252.40 million and an enterprise value of $279.29 million. This stock trades at a forward price-to-earnings of 9.45. Their estimated growth rate for this year is -36.9% and for next year it's pegged at -16%. This is not a cash-rich company, since the total cash position on their balance sheet is $11.13 million and their total debt is $54 million.A beneficial owner just bought 22,000 shares, or around $284,000 worth of stock, at $12.92 per share. This same beneficial owner has also bought over $2.6 million worth of stock since November 2011. From a technical standpoint, LHCG is currently trading below both its 50-day and 200-day moving averages, which is bearish. This stock recently found some big buying support at around $12.34 to $12.53 a share, which could mean the stock is putting in a near-term bottom. If you're bullish on LHCG, I would look to be a buyer off this stock if it can manage to sustain a move and close back above its 50-day moving average of $13.88 with volume. Look for volume that's near or above its three-month average action of 165,475 shares. You could also buy this stock off any weakness with a mental stop just below $12.34. I would then add to any long positions if LHCG takes out some near-term overhead resistance levels at $14.49 to $14.79 with volume.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV